-
Impact of Transfusion-Dependent Thalassemia on Adult Patients’ Health-Related Quality of Life and Work Productivity in the Kingdom of Saudi Arabia and United Arab Emirates
Sep 9, 2025, 16:22 PM -
Real-World Clinical and Economic Outcomes of Time in Range in Association With Diabetic Retinopathy Among Patients With Type I Diabetes
Sep 9, 2025, 16:22 PM -
Postherpetic Neuralgia Occurrence and Herpes Zoster Recurrence in Immunocompromised Adults Aged 18 Years or Older in England: A Large Retrospective Cohort Study (Clinical Practice Research Datalink 2012-2019)
Sep 9, 2025, 16:22 PM -
Economic Impact of Faricimab in Neovascular Age-Related Macular Degeneration Management in France
Sep 9, 2025, 16:22 PM -
Leveraging AI for Evidence Synthesis: Assessing the Accuracy and Efficiency of AI-Supported Data Extraction and Reporting
Sep 9, 2025, 16:22 PM -
Work Productivity Loss Among Caregivers of Pediatric Patients With COVID-19 OR Influenza/Influenza-Like Illness: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Assessing the Cost-Effectiveness of Lecanemab for Early Alzheimer's Disease Treatment: A Swiss Perspective
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Model of Ranolazine for Treating Chronic Stable Angina Patients From Kingdom of Saudi Arabia Perspective
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine From Lower-Valent Vaccines in the French Pediatric Population
Sep 9, 2025, 16:22 PM -
Applicability of the STEDI Value Framework to Vaccines in Health Technology Assessment: Opportunities and Considerations
Sep 9, 2025, 16:22 PM -
Exploring Methodologies for Defining and Modeling Cure in Melanoma: Impacts on Estimating Cure Metrics
Sep 9, 2025, 16:22 PM -
Payer and HTA Evaluation Criteria and Considerations for Coverage and Reimbursement of Patient Self-Monitoring Technology
Sep 9, 2025, 16:22 PM -
Harmonization or Hindrance? A Strategic Analysis of Divergent National Requirements Under the EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Measuring Quality of Life in Huntington’s Disease Using a Proxy Approach: Validation of the HD-mQoL-prx Measure
Sep 9, 2025, 16:22 PM -
Targeted Review of mITT vs. ITT Data in CAR-T Submissions
Sep 9, 2025, 16:22 PM -
Effectiveness of Psychosocial Interventions for Adults With Substance Use Disorder and Co-Occurring Mental Health Disorder: An Umbrella Review
Sep 9, 2025, 16:22 PM -
Environmental Sustainability in HTA: To What Extent Are HTA Bodies Considering Environmental Considerations in Their Decision Making?
Sep 9, 2025, 16:22 PM -
Patients With Lupus Across Germany: An AI/ML Driven Method to Maximize Patient Selection From Longitudinal Prescription Data (IQVIA LRx)
Sep 9, 2025, 16:22 PM -
Utilization of Glucagon-Like Peptide-1 Receptor Agonists in the Irish Healthcare System
Sep 9, 2025, 16:22 PM -
Utilizing the Patient-Specific Needs Evaluation for Data-Supported and Individualized Treatment (UNITE)
Sep 9, 2025, 16:22 PM
